Sign In
Buy HSCS
$2.07
+0.0500 (+2.48%)
At Close: Aug 10, 2026
Southlake, TX, Feb. 05, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company advan
Cibolo Health Designates HeartSciences' MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals
08:30am, Thursday, 29'th Jan 2026
Southlake, TX, Jan. 29, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focused
HeartSciences (NASDAQ:HSCS) & Health Catalyst (NASDAQ:HCAT) Critical Analysis
02:14am, Sunday, 21'st Dec 2025
HeartSciences (NASDAQ: HSCS - Get Free Report) and Health Catalyst (NASDAQ: HCAT - Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two bu
Market Today: Ford axes Lightning, iRobot bankrupt, Nvidia-China chips
05:36pm, Monday, 15'th Dec 2025
Stock News Ford pivots from full EV to hybrids and storage: Ford Motor (F) will discontinue the allâelectric Fâ150 Lightning and replace it with a plugâin
HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
04:15pm, Monday, 15'th Dec 2025
Southlake, TX, Dec. 15, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focused on advanc
HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device
08:30am, Monday, 15'th Dec 2025
Southlake, TX, Dec. 15, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company advanci
HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1
08:30am, Thursday, 11'th Dec 2025
Southlake, TX, Dec. 11, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company advancin
HeartSciences (HSCS) to Release Quarterly Earnings on Monday
01:20am, Monday, 08'th Dec 2025
HeartSciences (NASDAQ: HSCS - Get Free Report) is projected to release its results before the market opens on Monday, December 15th. Analysts expect HeartSciences to post earnings of ($0.90) per share
Reviewing Hims & Hers Health (NYSE:HIMS) and HeartSciences (NASDAQ:HSCS)
02:14am, Sunday, 07'th Dec 2025
Hims and Hers Health (NYSE: HIMS - Get Free Report) and HeartSciences (NASDAQ: HSCS - Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies
HeartSciences (NASDAQ:HSCS) and Bullfrog AI (NASDAQ:BFRG) Critical Analysis
02:36am, Sunday, 26'th Oct 2025
Bullfrog AI (NASDAQ: BFRG - Get Free Report) and HeartSciences (NASDAQ: HSCS - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses
HeartSciences Inc. (HSCS) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
10:56am, Tuesday, 21'st Oct 2025
After losing some value lately, a hammer chart pattern has been formed for HeartSciences Inc. (HSCS), indicating that the stock has found support. This, combined with an upward trend in earnings estim
HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results
04:15pm, Thursday, 11'th Sep 2025
Southlake, TX, Sept. 11, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (“AI”)-powered medical technology company
HeartSciences Announces Conference Participation and Investor Webinar
09:00am, Friday, 15'th Aug 2025
Virtual Events Include Investor Webinar and Presentation at Emerging Growth Conference 85 Virtual Events Include Investor Webinar and Presentation at Emerging Growth Conference 85
HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results
04:15pm, Thursday, 24'th Jul 2025
Southlake, TX, July 24, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (“AI”)-powered medical technology company t
HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis
09:00am, Wednesday, 04'th Jun 2025
Southlake, TX, June 04, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (“AI”) powered medical technology c
